GRACE THERAPEUTICS INC

Grace Therapeutics, a Nasdaq‑listed specialty pharma, drives breakthrough drug delivery for rare and orphan diseases in Canada & the U.S., balancing innovation with investor confidence.

Grace Therapeutics Inc. has experienced significant fluctuations in its stock price and faces financial instability, but its focus on rare and orphan diseases presents opportunities for growth in the competitive pharmaceutical sector.